Healthcare provider profile · identity verified

Jon B Gardner, MD

Internal Medicine · WALLA WALLA, WA · NPI 1447264841

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	660	183
Losartan Potassium	Losartan Potassium	369	104
Omeprazole	Omeprazole	356	96
Levothyroxine Sodium	Levothyroxine Sodium	350	83
Lisinopril	Lisinopril	266	75
Hydrochlorothiazide	Hydrochlorothiazide	202	52
Metformin Hcl	Metformin Hcl	196	51
Potassium Chloride	Potassium Chloride	193	53
Eliquis	Apixaban	192	38
Amlodipine Besylate	Amlodipine Besylate	186	48
Metoprolol Succinate	Metoprolol Succinate	183	55
Tamsulosin Hcl	Tamsulosin Hcl	170	53
Furosemide	Furosemide	154	41
Simvastatin	Simvastatin	154	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	141	35
Escitalopram Oxalate	Escitalopram Oxalate	135	30
Rosuvastatin Calcium	Rosuvastatin Calcium	131	36
Oxycodone Hcl	Oxycodone Hcl	118	21
Gabapentin	Gabapentin	112	27
Xarelto	Rivaroxaban	108	21
Alendronate Sodium	Alendronate Sodium	102	24
Citalopram Hbr	Citalopram Hydrobromide	101	27
Metoprolol Tartrate	Metoprolol Tartrate	101	26
Albuterol Sulfate Hfa	Albuterol Sulfate	83	29
Zolpidem Tartrate	Zolpidem Tartrate	83	33
Allopurinol	Allopurinol	78	23
Finasteride	Finasteride	78	22
Prednisone	Prednisone	74	35
Warfarin Sodium	Warfarin Sodium	70	12
Pantoprazole Sodium	Pantoprazole Sodium	68	20
Sertraline Hcl	Sertraline Hcl	68	16
Glimepiride	Glimepiride	66	22
Ozempic	Semaglutide	66	12
Ezetimibe	Ezetimibe	65	13
Montelukast Sodium	Montelukast Sodium	65	15
Duloxetine Hcl	Duloxetine Hcl	62	suppressed
Rybelsus	Semaglutide	62	12
Synthroid	Levothyroxine Sodium	61	13
Meloxicam	Meloxicam	58	19
Alprazolam	Alprazolam	55	22
Quetiapine Fumarate	Quetiapine Fumarate	55	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	15
Mounjaro	Tirzepatide	52	suppressed
Donepezil Hcl	Donepezil Hcl	51	12
Fluticasone Propionate	Fluticasone Propionate	50	26
Felodipine Er	Felodipine	49	suppressed
Celecoxib	Celecoxib	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	12
Venlafaxine Hcl Er	Venlafaxine Hcl	45	12
Digoxin	Digoxin	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	12
Levetiracetam	Levetiracetam	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	11
Spironolactone	Spironolactone	41	11
Triamcinolone Acetonide	Triamcinolone Acetonide	39	17
Atenolol	Atenolol	38	suppressed
Lorazepam	Lorazepam	38	14
Pregabalin	Pregabalin	37	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	12
Topiramate	Topiramate	35	suppressed
Jardiance	Empagliflozin	33	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Nitroglycerin	Nitroglycerin	31	22
Acyclovir	Acyclovir	30	11
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Famotidine	Famotidine	29	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Carvedilol	Carvedilol	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Trazodone Hcl	Trazodone Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	20
Estradiol	Estradiol	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Cephalexin	Cephalexin	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Mesalamine Er	Mesalamine	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Movantik	Naloxegol Oxalate	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Methylprednisolone	Methylprednisolone	22	17
Testosterone	Testosterone	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Azithromycin	Azithromycin	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	13
Enbrel Sureclick	Etanercept	15	suppressed
Febuxostat	Febuxostat	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Depakote	Divalproex Sodium	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lamictal	Lamotrigine	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Primidone	Primidone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Dapsone	Dapsone	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error